Immunogenicity of a new, inactivated canine adenovirus type 2 vaccine for dogs

Purpose We constructed a new canine adenovirus type 2 (CAV-2) vaccine candidate using the recently isolated Korean CAV-2 strain; we termed the vaccine APQA1701-40P and evaluated its safety and immunogenicity in dogs. Materials and Methods To generate the anti-CAV-2 vaccine, APQA1701 was passaged 40 times in MDCK cells growing in medium containing 5 mM urea and the virus was inactivated using 0.05% (volume per volume) formaldehyde. Two vaccines were prepared by blending inactivated APQA1701-40P with two different adjuvants; both were intramuscularly injected (twice) into guinea pigs. The safety and immunogenicity of the Cabopol-adjuvanted vaccine were evaluated in seronegative dogs. The humoral responses elicited were measured using an indirect enzyme-linked immunosorbent assay (I-ELISA), and via a virus neutralization assay (VNA). Results The new, inactivated CAV-2 vaccine strain, APQA1701-40P, lacked six amino acids of the E1b-19K protein. In guinea pigs, the Cabopol-adjuvanted vaccine afforded a slightly higher VNA titer and I-ELISA absorbance than an IMS gel-adjuvanted vaccine 4 weeks post-vaccination (p>0.05). Dogs inoculated with the former vaccine developed a significantly higher immune titer than non-vaccinated dogs. Conclusion The Cabopol-adjuvanted, inactivated CAV-2 vaccine was safe and induced a high VNA titer in dogs.

[1]  X. Wen,et al.  Enhanced Immune Responses Against Japanese Encephalitis Virus Infection Using Japanese Encephalitis Live-Attenuated Virus Adjuvanted with Montanide GEL 01 ST in Mice. , 2019, Vector borne and zoonotic diseases.

[2]  Ha-Hyun Kim,et al.  Recharacterization of the Canine Adenovirus Type 1 Vaccine Strain based on the Biological and Molecular Properties , 2019, Journal of Bacteriology and Virology.

[3]  Hyunkyoung Lee,et al.  Isolation and identification of canine adenovirus type 2 from a naturally infected dog in Korea , 2018, Korean Journal of Veterinary Research.

[4]  Ha-Hyun Kim,et al.  Incidence and Sero-survey of Canine Adenovirus Type 2 in Various Animal Species , 2018 .

[5]  F. Alkan,et al.  Detection and molecular characterization of canine adenovirus type 2 (CAV-2) in dogs with respiratory tract symptoms in shelters in Turkey , 2018, Veterinarski arhiv.

[6]  Yufeng Li,et al.  Evaluation of carbopol as an adjuvant on the effectiveness of progressive atrophic rhinitis vaccine. , 2018, Vaccine.

[7]  K. Stadler,et al.  Carbopol improves the early cellular immune responses induced by the modified-life vaccine Ingelvac PRRS® MLV. , 2015, Veterinary microbiology.

[8]  J. Oem,et al.  CANINE ADENOVIRUS TYPE 1 IN A FENNEC FOX (VULPES ZERDA) , 2014, Journal of zoo and wildlife medicine : official publication of the American Association of Zoo Veterinarians.

[9]  F. Gulland,et al.  Isolation of a novel adenovirus from California sea lions Zalophus californianus. , 2011, Diseases of aquatic organisms.

[10]  R. Coffman,et al.  Vaccine adjuvants: putting innate immunity to work. , 2010, Immunity.

[11]  Jae-Young Song,et al.  Comparison of the diagnostic methods on the canine adenovirus type 2 infection , 2010, Basic and applied pathology.

[12]  W. Russell,et al.  Adenoviruses: update on structure and function. , 2009, The Journal of general virology.

[13]  M. C. Lee,et al.  Canine Adenovirus Type 1 Infection of a Eurasian River Otter (Lutra lutra) , 2007, Veterinary pathology.

[14]  K. Henrickson,et al.  Rapid Detection and Identification of Human Adenovirus Species by Adenoplex, a Multiplex PCR-Enzyme Hybridization Assay , 2004, Journal of Clinical Microbiology.

[15]  Z. Zhong,et al.  Detection and Differentiation of CAV-1 and CAV-2 by Polymerase Chain Reaction , 2004, Veterinary Research Communications.

[16]  G. Chinnadurai,et al.  Functional similarity between adenovirus e1b 19k gene and bcl2 oncogene - mutant complementation and suppression of cell-death induced by DNA-damaging agents. , 1993, International journal of oncology.

[17]  J. M. Boyd,et al.  Mutational analysis of the transforming and apoptosis suppression activities of the adenovirus E1B 175R protein. , 1993, Gene.

[18]  N. Spibey,et al.  A mutant of canine adenovirus type 2 with a duplication of the E1a region exhibits altered expression of early region 4. , 1991, The Journal of general virology.

[19]  E. White,et al.  Adenovirus E1B 19-kilodalton protein overcomes the cytotoxicity of E1A proteins , 1991, Journal of virology.

[20]  J. Campbell,et al.  Multiple reiteration of a 40-bp nucleotide sequence in the inverted terminal repeat of the genome of a canine adenovirus. , 1987, Virology.

[21]  I. McCandlish,et al.  Immunity to canine adenovirus respiratory disease: a comparison of attenuated CAV-1 and CAV-2 vaccines , 1982, Veterinary Record.

[22]  D. Robson,et al.  Canine adenovirus type 2-induced immunity to two canine adenoviruses in pups with maternal antibody. , 1975, American journal of veterinary research.